Hemlibra 150 mg/mL solution for injection
MO42623
Approved small_molecule active
Quick answer
Hemlibra 150 mg/mL solution for injection for Severe or Moderate Hemophilia A is a Approved program (small_molecule) at Hoffmann-La Roche with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hoffmann-La Roche
- Indication
- Severe or Moderate Hemophilia A
- Phase
- Approved
- Modality
- small_molecule
- Status
- active